IBDEI13T ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,19479,2)
 ;;=^295219
 ;;^UTILITY(U,$J,358.3,19480,0)
 ;;=V10.05^^105^1232^59
 ;;^UTILITY(U,$J,358.3,19480,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19480,1,4,0)
 ;;=4^V10.05
 ;;^UTILITY(U,$J,358.3,19480,1,5,0)
 ;;=5^H/O Colon Cancer
 ;;^UTILITY(U,$J,358.3,19480,2)
 ;;=H/O Colon Cancer^295207
 ;;^UTILITY(U,$J,358.3,19481,0)
 ;;=V10.03^^105^1232^60
 ;;^UTILITY(U,$J,358.3,19481,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19481,1,4,0)
 ;;=4^V10.03
 ;;^UTILITY(U,$J,358.3,19481,1,5,0)
 ;;=5^H/O Esophageal Cancer
 ;;^UTILITY(U,$J,358.3,19481,2)
 ;;=^295205
 ;;^UTILITY(U,$J,358.3,19482,0)
 ;;=V10.60^^105^1232^62
 ;;^UTILITY(U,$J,358.3,19482,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19482,1,4,0)
 ;;=4^V10.60
 ;;^UTILITY(U,$J,358.3,19482,1,5,0)
 ;;=5^H/O Leukemia
 ;;^UTILITY(U,$J,358.3,19482,2)
 ;;=H/O Leukemia^295231
 ;;^UTILITY(U,$J,358.3,19483,0)
 ;;=V10.11^^105^1232^63
 ;;^UTILITY(U,$J,358.3,19483,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19483,1,4,0)
 ;;=4^V10.11
 ;;^UTILITY(U,$J,358.3,19483,1,5,0)
 ;;=5^H/O Lung Cancer
 ;;^UTILITY(U,$J,358.3,19483,2)
 ;;=H/O Lung Cancer^295211
 ;;^UTILITY(U,$J,358.3,19484,0)
 ;;=V10.79^^105^1232^64
 ;;^UTILITY(U,$J,358.3,19484,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19484,1,4,0)
 ;;=4^V10.79
 ;;^UTILITY(U,$J,358.3,19484,1,5,0)
 ;;=5^H/O Lymphoma
 ;;^UTILITY(U,$J,358.3,19484,2)
 ;;=H/O Lymphoma^295238
 ;;^UTILITY(U,$J,358.3,19485,0)
 ;;=V10.82^^105^1232^65
 ;;^UTILITY(U,$J,358.3,19485,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19485,1,4,0)
 ;;=4^V10.82
 ;;^UTILITY(U,$J,358.3,19485,1,5,0)
 ;;=5^H/O Malig Melanoma Of Skin
 ;;^UTILITY(U,$J,358.3,19485,2)
 ;;=^295240
 ;;^UTILITY(U,$J,358.3,19486,0)
 ;;=V10.02^^105^1232^68
 ;;^UTILITY(U,$J,358.3,19486,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19486,1,4,0)
 ;;=4^V10.02
 ;;^UTILITY(U,$J,358.3,19486,1,5,0)
 ;;=5^H/O Oral Cavity/Pharynx Cancer
 ;;^UTILITY(U,$J,358.3,19486,2)
 ;;=^295204
 ;;^UTILITY(U,$J,358.3,19487,0)
 ;;=V10.43^^105^1232^69
 ;;^UTILITY(U,$J,358.3,19487,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19487,1,4,0)
 ;;=4^V10.43
 ;;^UTILITY(U,$J,358.3,19487,1,5,0)
 ;;=5^H/O Ovarian Cancer
 ;;^UTILITY(U,$J,358.3,19487,2)
 ;;=^295221
 ;;^UTILITY(U,$J,358.3,19488,0)
 ;;=V10.46^^105^1232^70
 ;;^UTILITY(U,$J,358.3,19488,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19488,1,4,0)
 ;;=4^V10.46
 ;;^UTILITY(U,$J,358.3,19488,1,5,0)
 ;;=5^H/O Prostate Cancer
 ;;^UTILITY(U,$J,358.3,19488,2)
 ;;=^295224
 ;;^UTILITY(U,$J,358.3,19489,0)
 ;;=V10.06^^105^1232^71
 ;;^UTILITY(U,$J,358.3,19489,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19489,1,4,0)
 ;;=4^V10.06
 ;;^UTILITY(U,$J,358.3,19489,1,5,0)
 ;;=5^H/O Rectal/Anal Cancer
 ;;^UTILITY(U,$J,358.3,19489,2)
 ;;=^295208
 ;;^UTILITY(U,$J,358.3,19490,0)
 ;;=V10.52^^105^1232^72
 ;;^UTILITY(U,$J,358.3,19490,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19490,1,4,0)
 ;;=4^V10.52
 ;;^UTILITY(U,$J,358.3,19490,1,5,0)
 ;;=5^H/O Renal Cancer
 ;;^UTILITY(U,$J,358.3,19490,2)
 ;;=H/o Renal Cancer^295229
 ;;^UTILITY(U,$J,358.3,19491,0)
 ;;=V10.04^^105^1232^74
 ;;^UTILITY(U,$J,358.3,19491,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19491,1,4,0)
 ;;=4^V10.04
 ;;^UTILITY(U,$J,358.3,19491,1,5,0)
 ;;=5^H/O Stomach Cancer
 ;;^UTILITY(U,$J,358.3,19491,2)
 ;;=^295206
 ;;^UTILITY(U,$J,358.3,19492,0)
 ;;=V10.47^^105^1232^75
 ;;^UTILITY(U,$J,358.3,19492,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19492,1,4,0)
 ;;=4^V10.47
 ;;^UTILITY(U,$J,358.3,19492,1,5,0)
 ;;=5^H/O Testicular Cancer
 ;;^UTILITY(U,$J,358.3,19492,2)
 ;;=^295225
 ;;^UTILITY(U,$J,358.3,19493,0)
 ;;=V10.83^^105^1232^73
 ;;
 ;;$END ROU IBDEI13T
